CompletedNot Applicable

Breathing Exercises Effect on Lung Functions and Chest Expansion in Asthmatics

Egypt60 participantsStarted 2022-10-15

Plain-language summary

The goal for this clinical trial was to compare the effectiveness of Diaphragmatic Breathing and Pursed-Lip Expiration Exercises in improving lung functions {the Peak Expiratory Flow Rate (PEFR) and Forced Expiratory Volume in 1- second (FEV1)} and Chest Expansion in Egyptian outpatient adults with bronchial asthma. The research questions were: 1. Are Diaphragmatic Breathing Exercises effective in improving lung function parameters? 2. Are Pursed-Lip Expiration Exercises effective in improving lung function parameters? 3. Which of the two studied breathing exercise is more effective in improving lung function parameters? All the participants were classified into 2 groups: Group1: Diaphragmatic Breathing Exercise training was offered for participants to complete the 8-weeks exercise program (each session lasted about 20 minutes twice daily for 5 days per week). Group2: Pursed Lip Breathing Exercise training was offered for participants to complete the 8-weeks exercise program (each session lasted about 20 minutes twice daily for 5 days per week). The two main parameters which were assessed initially and after completion of the 2-month exercise program were: 1. Lung functions {Peak Expiratory Flow Rate (PEFR) and Forced Expiratory Volume in 1-second (FEV1)} 2. The chest expansion

Who can participate

Age range

18 Years – 60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Egyptian adults aged between 18 and 60 years old, both males and females. * Pulmonary function-based diagnosis for asthma. * Mild and moderate cases of asthma. Exclusion Criteria: * Recent myocardial infarction or acute coronary syndrome. * Non-cooperative patients. * Status asthmatics patients. * Hypoxic patients. * Asthmatic patients who were associated with other chest and heart diseases. * Recent pneumothorax or pulmonary embolism. * Large thoracic or abdominal aortic aneurysm. * Acute onset of hemoptysis. * Retinal detachment. * Intracranial hypertension. * Patients with dementia. * Recent brain, eye, ear, nose, abdominal or thoracic surgery. * Severe uncontrolled hypertension. * Patients with urinary incontinence. * Currently admitted to intensive care unit.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Changes in FEV1

Timeframe: 8 weeks

Changes in PEFR

Timeframe: 8 WEEKS

Changes in chest expansion

Timeframe: 8 weeks

Trial details

NCT IDNCT07477080

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03-13

View on ClinicalTrials.gov More Asthma Chronic trials